Episode nine takes an in-depth look at ALS Research and the therapy development process with Dr. Jill Yersak, Senior Director of Mission Strategy at The ALS Association. Dr. Yersak discusses promising potential treatments in the pipeline (including NurOwn) and provides excellent insight into the FDA’s approval process. Our conversation concludes with information about an upcoming feedback and data collection initiative called ALS Focus, which you’ll be hearing more about in the near future.
Dr. Yersak mentions a few valuable resources during the episode, including; the official ALS Association Blog, the National ALS Registry, and a place where you can direct questions about research and anything else related to ALS — email@example.com
Find a transcript of this episode soon on Tumblr.
This episode was produced by Garrett Tiedemann and is brought to you by the Connectivity Center at the ALS Association MN/ND/SD Chapter.